Innovation is one of the themes that Pieter Droppert writes about on the Biotech Strategy Blog. As management consultants we are interested in new product development strategy, and how to bring novel drugs and devices to market.
In his latest blog post, Pieter discusses an article published on the Harvard Business Review blog that suggests we may be able to learn from how innovation is taking place in emerging markets.
Emerging markets, in particular the BRIC countries: Brazil, Russia, India & China, are driving the growth of the world’s leading pharmaceutical companies. It’s interesting to think that the developed world may be able to learn from emerging economies.